Hybrid Associate Director, In Vivo Toxicology

Crispr Therapeutics Inc in

Boston (MA)

Hybrid

USD 160,000 - 180,000

Full time

8 days ago

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

CRISPR Therapeutics, Inc. seeks an experienced toxicologist to advance IND-enabling pharmacology studies for in vivo programs.

The role reports to the Director, Head of in vivo Toxicology and acts as a cross-functional SME across toxicology, pharmacology and DMPK to drive nonclinical strategy. Remote work is allowed with a minimum on-site presence; associated duties include collaboration across teams, authoring non-clinical sections for regulatory filings, and supporting early development

Qualifications

  • Ph.D. in toxicology or related field with 8+ years of relevant experience.
  • Master’s in toxicology or related field with 15+ years of relevant experience is acceptable.

Responsibilities

  • Designs non-clinical non-GLP and GLP studies; prepares protocols and supervises studies.
  • Supports resourcing for pharmacology, toxicology, and DMPK activities from in vivo studies to IND/LICENSURE.
  • Ensures studies meet FDA/CHMP/WHO/GLP/ISO standards and guidelines.

Skills

IND experience
GLP toxicology
DMPK
CRO outsourcing
Regulatory interactions

Education

PhD toxicology
Master's toxicology

Tools

IB/IND documents

Job description

CRISPR Therapeutics, Inc. seeks an experienced toxicologist to advance IND-enabling pharmacology studies for in vivo programs.

The role reports to the Director, Head of in vivo Toxicology and acts as a cross-functional SME across toxicology, pharmacology and DMPK to drive nonclinical strategy. Remote work is allowed with a minimum on-site presence; associated duties include collaboration across teams, authoring non-clinical sections for regulatory filings, and supporting early development

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Associate Director, In Vivo Toxicology — Hybrid/Remote
Associate Director, In Vivo Toxicology — Hybrid/Remote

CRISPR Therapeutics • Boston (MA)

Hybrid
USD 180,000 - 240,000
Strategic Associate Director, In Vivo Toxicology
Strategic Associate Director, In Vivo Toxicology

Crispr Therapeutics AG • Boston (MA)

On-site
USD 160,000 - 180,000
Bonus potential
Equity
In Vivo Toxicology: Associate Director, IND-Enabling
In Vivo Toxicology: Associate Director, IND-Enabling

CRISPR Therapeutics, Inc. • Boston (MA)

Hybrid
USD 160,000 - 180,000
Bonus and equity
Senior In Vivo Toxicology Lead for IND Programs
Senior In Vivo Toxicology Lead for IND Programs

Crispr Therapeutics AG • Massachusetts

On-site
USD 160,000 - 180,000
Bonus
Equity
Benefits
Associate Director, in vivo Toxicology
Associate Director, in vivo Toxicology

CRISPR Therapeutics • Boston (MA)

Hybrid
USD 180,000 - 240,000
Associate Director, in vivo Toxicology
Associate Director, in vivo Toxicology

Crispr Therapeutics AG • Boston (MA)

On-site
USD 160,000 - 180,000
Bonus potential
Equity
Associate Director, in vivo Toxicology
Associate Director, in vivo Toxicology

CRISPR Therapeutics • Massachusetts

On-site
USD 160,000 - 180,000
Bonus
Equity
Benefits
Senior In Vivo Pharmacology Scientist (CRISPR)
Senior In Vivo Pharmacology Scientist (CRISPR)

Scribe Therapeutics • Alameda (CA)

On-site
USD 120,000 - 180,000
Health benefits (medical, dental, VSA)
Meaningful equity
Wellness stipend
+3
Associate Director, in vivo Toxicology
Associate Director, in vivo Toxicology

Crispr Therapeutics Inc in • Boston (MA)

Hybrid
USD 160,000 - 180,000
Director, Nonclinical Development - In Vivo Toxicology
Director, Nonclinical Development - In Vivo Toxicology

UroGen Pharma, Inc. • Philadelphia

Hybrid
USD 180,000 - 240,000
Medical
Dental
Vision
+3